Cells in the mammalian blastocyst segregate into three distinct lineages, namely, trophoblast, hypoblast, and epiblast. During development, these will form extraembryonic and embryonic tissues, respectively. In mouse, only epiblast cells can be directly converted into cultured pluripotent embryonic stem cells, capable of forming all adult cell types. This conversion is promoted by the double inhibition (i.e., 2i) of mitogen-activated protein kinase kinase (Map2k), antagonizing Fgf signaling, and of glycogen synthase kinase 3 (Gsk3), stimulating the Wnt pathway. We investigated the effect of 2i treatment on lineage segregation and pluripotency-related gene expression in bovine blastocysts. In vitro fertilized (IVF) embryos were cultured in the presence of dimethyl sulfoxide or inhibitors of MAP2K (0.4 lM PD0325901) and GSK3 (3 lM CHIR99021) from the zygote (Day 1) stage. Compared to vehicle controls, 2i conditions increased the abundance of cumulus cells in bovine IVF cultures, which compromised blastocyst formation. Following cumulus removal, 2i accelerated blastocyst development and increased inner cell mass (ICM) and trophoblast cell numbers by 30% and 27%, respectively. These developmental and morphological changes were accompanied by alterations in gene expression. Signal inhibition increased transcription of putative epiblast markers NANOG and SOX2 while repressing putative hypoblast marker GATA4. Using microsurgical blastocyst dissection, we found that the increase in NANOG and SOX2 levels was specific to the ICM and not due to ectopic expression in the trophoblast. Expression of other pluripotency-related (POU5F1, KLF4, DPPA3) or trophoblast-enriched (CDX2) genes was not affected. In summary, 2i conditions reprogrammed the transcriptional profile of bovine ICM but not trophoblast cells. By shifting the balance from hypoblast-to epiblast-associated gene expression, 2i culture may prime bovine epiblast for subsequent derivation of pluripotent stem cell cultures.
INTRODUCTION
Following fertilization, the zygote cleaves into progressively smaller nucleated blastomeres. At the morula stage, these blastomeres compact into a tight ball, consisting of an epithelial outer layer and an internalized group of cells, which develop into the trophoblast and inner cell mass (ICM or pluriblast) of the early blastocyst, respectively. The trophoblast will form extraembryonic structures, specifically the fetal part of the placenta (the chorion), while the ICM segregates into the epiblast (or primitive ectoderm) and the hypoblast (or primitive endoderm). Embryonic pluripotent stem cells (ePSCs), capable of producing all the cell types in an adult animal, experimentally originate from microdissected single epiblast cells [1] . The epiblast and hypoblast form morphologically and molecular distinct cell populations that subsequently develop into the embryo proper and extraembryonic yolk sac, respectively. The chronological sequence of early developmental events is similar between mouse and cattle [2] . However, the timing of fertilization, cleavage, compaction, and blastulation differs, encompassing 7 days, compared to 3.5 days in mouse. Bovine blastocysts, also containing a trophoblast outer epithelial single cell layer and a compact ICM, are about twice the size of mouse, both in cell numbers and diameter. Following blastulation, hypoblast cells become morphologically distinct from the underlying epiblast cells of the former ICM [3] . Concomitant with this emerging lineage divergence, the blastocyst expands through fluid accumulation in the blastocoel cavity and hatches from the zona pellucida around Embryonic Day 8-9 (D8-D9) post-IVF (in vitro fertilization) [3] .
In mouse, trophoblast and epiblast are marked by mosaic expression of several transcription factors, namely, Cdx2, Pouf51 (better known as Oct4), Sox2, and Nanog [4] . While Cdx2 is trophoblast-specific, the molecular identity of the nascent epiblast is mainly determined by Pou5f1, Sox2, and Nanog. Collectively, Pou5f1, Sox2, and Nanog function as activators of gene expression rather than repressors [5] . During blastocyst formation, Pouf51 and Sox2 are gradually downregulated in the trophoblast and become restricted to the ICM [6, 7] . Pouf51 is required to establish the developmental potential of ICM cells. In its absence, neither hypoblast nor epiblast is produced, and all the ICM cells eventually differentiate into trophoblast [8] . However, within the differentiating ICM, Pouf51 is also expressed in the hypoblast [7] and therefore cannot alone be sufficient to specify those epiblast cells destined to become pluripotent. Nanog expression, on the other hand, is tightly correlated with the nascent epiblast and mutually exclusive with the hypoblast marker Gata6 [9] [10] [11] . Gene deletion studies have shown that, like Pouf51, Nanog-deficient ICM fails to generate epiblast [12] . Sox2 is thought to maintain Pouf51 expression, and its deletion largely phenocopies the Pouf51 deletion [13] . However, knockdown of maternal Sox2 has also suggested an earlier role of Sox2 in establishing trophoblast fate [6] .
Several signaling pathways are crucial in establishing the emerging epiblast and protecting it from extraembryonic differentiation. Secreted Fgf4, autocrinally produced in naive epiblast cells [14] , activates the mitogen-activated protein kinase (Mapk) module, which consists of Mapk kinase 1/2 (Map2k, also known as Mapkk or Mek) and Mapk1/2 (Erk). This activation induces lineage commitment [15] . Accordingly, pharmacological inhibition of the Mapk pathway shields epiblast cells from inductive Fgf signals and effectively blocks their differentiation. In vivo, this prevents epiblast cells from diverting into extraembryonic lineages, resulting in epiblast expansion at the expense of hypoblast tissue [16] . Wnt proteins also antagonize Fgf/Mapk and can be indirectly stimulated by partial inhibition of glycogen synthase kinase 3 (Gsk3) [17, 18] . The double inhibition (i.e., 2i) of Gsk3 and Map2k effectively promotes pluripotency in several murine PSC types [19] [20] [21] . It also led to the first derivation of fully pluripotent (naive) ePSCs from previously recalcitrant mouse strains and rat embryos [22, 23] . Thus, progress in our understanding of pluripotency regulation in the mouse has led to the development of chemically defined culture conditions that are based on the inhibition of Fgf/Mapk signaling and stimulation of Wnt/ Gsk3 signaling. These recent advances suggest that the naive pluripotent state may be a conserved feature of mammalian embryogenesis that could be captured in cattle and other livestock species.
Consistent with the longer period of preimplantation development, gene expression profiles in bovine embryos differ from the mouse. For example, POUF51 mRNA and protein persist for some time in both trophoblast and hypoblast before becoming gradually epiblast exclusive after hatching [24] [25] [26] [27] . Bovine NANOG first appears in a subset of ICM cells before becoming epiblast restricted and mutually exclusive with the hypoblast marker GATA6 in D8 blastocysts [28] . Similar to NANOG, bovine SOX2 mRNA and protein expression is also progressively limited to the ICM and epiblast [29] . Outside the core pluripotency network, naive epiblast markers DPPA3 and KLF4 have not been investigated in detail in bovine but show no consistent expression level differences between porcine ICM versus epiblast [30] .
Prompted by the robust effects of 2i culture in rodents, we have probed the existence of a pluripotent ground state in cattle embryos. We found that 2i instructed bovine ICM cells to increase epiblast-specific genes and repress hypoblast-specific genes, while lineage-specific marker expression in the trophoblast was not obstructed. This suggests that complete MAPK inhibition resulted in a partial conversion of prospective hypoblast into epiblast tissue without affecting trophoblast formation and maintenance. As a result of such pluripotency priming, the epiblast of 2i-cultured blastocysts may be more amenable to subsequent ePSC derivation.
MATERIALS AND METHODS
Chemicals were purchased from Sigma-Aldrich, and all the embryo manipulations were carried out at 38.58C unless indicated otherwise. All the experiments were direct contemporaneous comparisons, that is, within each IVF run, all the parameters other than the culture condition (dimethyl sulfoxide [DMSO] versus 2i) were kept the same.
In Vitro Production of Embryos
In vitro matured (IVM) oocytes were derived from slaughterhouse ovaries of mixed breed dairy cows as described previously [31] . IVM oocytes were fertilized at 20-22 h after the start of maturation as described previously [32] . Spermatozoa were prepared from commercially obtained frozen-thawed semen from a sire with proven in vitro fertility. The contents of two 0.25 ml straws were layered upon a Percoll gradient (45%:90%), and motile spermatozoa were collected after centrifugation at 700 3 g for 20 min at room temperature. Fertilization was performed in 50 ll IVF synthetic oviduct fluid (SOF) as described previously [31] . For cumulus-free cultures, the corona was dispersed after IVF for 22-24 h by vortexing oocytes in 500 ll of 1 mg/ml bovine testicular hyaluronidase in Hepes-buffered SOF (HSOF), followed by two washes in HSOF. For in vitro culture (IVC), 10 embryos were pooled in 20 ll of early SOF medium [33] and cultured for 7 days (D0: fertilization). On D5, embryos were changed into fresh late SOF (LSOF) drops containing 10 lM 2,4-dinitrophenol [32] . The culture medium was supplemented with MAP2K inhibitor PD0325901 (10 mM stock, 0.4 lM final concentration; Stemgent) and GSK3B inhibitor CHIR99021 (10 mM stock, 3 lM final concentration; Stemgent) (i.e., 2i). In pilot experiments, 2i medium contained additional FGFR inhibitor PD173074 (1 mM stock, 0.1 lM final concentration) (Sigma) (i.e., 3i). For the initial experiments, 2i reagents were kindly donated by Stem Cell Sciences Pty Ltd. All the inhibitor stocks were dissolved in DMSO, and the solvent controls contained 0.3% DMSO in the culture medium. Embryo cultures were overlaid with mineral oil and kept in a humidified modular incubation chamber (ICN Biomedicals Inc.) gassed with 5% CO 2 , 7% O 2 , and 88% N 2 . Embryos were categorized on D7 according to developmental stage as early, mid, expanded, or hatched blastocyst (EB, MB, XB or HB, respectively) and morphologically graded as described [34] .
Differential Staining
Expanded grade 1 and 2 blastocysts (XB [1] [2] ) were treated with pronase to remove the zona pellucida [35] and exposed to a 1:4 dilution in Hepes-buffered transfer LSOF (THSOF) of rabbit anti-bovine whole serum (B3759; Sigma) for 45 min, rinsed in THSOF with 0.1 mg/ml cold soluble polyvinyl alcohol (molecular weight: 10 000-30 000) (THSOF-PVA), and placed into a 1:4 dilution in THSOF of guinea pig complement (Sigma, S1639) containing 5 lg/ ml propidium iodide and 40 lg/ml Hoechst 33342 for 15 min. After rinsing in THSOF-PVA, the embryos were mounted (DAKO mounting medium; MedBio Ltd.) on glass slides and examined using an epifluorescence microscope (AX-70; Olympus). Blue and pink colors were designated as ICM and trophectoderm (TE) cells, respectively [36] , and cell numbers were quantified the same day using Scion Image software (Beta4.0.2, 2000).
Blastocyst Bisection
Zona-free XB 1-2 were washed in PBS-PVA (0.1 mg/ml) and drops of protein-free THSOF-PVA before attaching them to the lid of a Petri dish in protein-free THSOF. A microsurgical splitting blade (ESE020; Bioniche Animal Health Inc.), mounted to a three-axis oil hydraulic hanging joystick micromanipulator (MO-188; Nikon Narishige), was lowered to separate the ICM from the majority of the trophoblast tissue. Separated tissues were washed in HSOF and processed for RNA extraction.
Isolation and Culture of ICMs
ICMs were immunosurgically isolated from zona-free XB 1-2 as described above but without including dyes in the guinea pig complement. Isolated ICMs were seeded on glass coverslips coated with natural mouse laminin (Life Technologies) and gelatin. Cells were cultured in Dulbecco modified Eagle medium/F12 (Life Technologies), N2 supplement (Life Technologies) mixed 1:1 with Neurobasal medium (Life Technologies), B27 supplements (Life Technologies), and 1 mM L-glutamine (i.e., N2B27), and supplemented with 2i. After 6 days in culture, the RNA was extracted from primary colonies.
RNA Extraction and RT-PCR
Pools of whole or bisected blastocysts were lysed in TRIzol (Life Technologies), and cDNA was synthesized as described previously [37] . Reverse transcriptase was omitted in one sample each time a batch was processed for cDNA synthesis. A Mastercycler gradient (Eppendorf) or Thermal Cycler (Bio-Rad) was used for PCR amplification using primers shown in Table 1 . PCR was performed using the following conditions: one cycle denaturation at 958C for 5 min, followed by 35 cycles of 30 sec at 958C, 30 sec at 558C-608C (see Table 1 for primer-specific annealing temperatures), 30 sec at 728C, 7 min extension at 728C, and cooling to 48C. For quantitative PCR (qPCR), a LightCycler (Roche) was used. All the reactions were performed with the LightCycler FastStart DNA MasterPLUS SYBR Green I kit. Primers were designed using LightCycler Probe Design 2.0 or NCBI/ Primer-BLAST. The ready-to-use Hot Start LightCycler reaction mix consisted of 0.4 ll of each primer (10 lM), 2.0 ll LightCycler SYBR Green I master HARRIS ET AL. mix, 5.2 ll diethylpyrocarbonate-treated water, 1.0 ll DMSO if required, and 1-2.0 ll cDNA template. The following four-segment program was used: 1) denaturation (10 min at 958C), 2) amplification and quantification (20 sec at 958C, 20 sec at 558C-608C, followed by 20 sec at 728C with a single fluorescent measurement repeated 45 times), 3) melting curve (958C, then cooling to 658C for 20 sec, followed by heating at 0.28C/sec to 958C while continuously measuring the fluorescence), and 4) cooling to 48C. Product identity was confirmed by gel electrophoresis and melting curve analysis. For relative quantification, external standard curves were generated from serial 5-log dilutions for each gene in duplicate. One high-efficiency curve (3.6 ! slope ! 3.1, R 2 . 0.99) was saved for each target gene and imported for relative quantification as described previously [37] .
Statistical Analysis
Statistical significance was accepted at P , 0.05 and determined using the two-tailed Fisher exact test for independence in 2 3 2 tables for developmental data ( Figs. 1 and 2 ) or the two-tailed Student t-test with equal variance for the cell counts and qPCR data ( Table 2 
RESULTS

2i Improves Bovine Blastocyst Formation
Bovine IVF embryos were cultured in the presence of FGF-MAPK and GSK3 inhibitors from the zygote (D1), 8-cell (D3), or morula stage (D5) onward. Compared to vehicle controls, none of these culture regimens interfered with the formation of morphologically normal blastocysts in vitro (Fig. 1A) . In order to maximize the exposure time without interfering with development, we subsequently cultured all the embryos in the presence of the inhibitors from D1 onward. Whilst our initial experiments included a specific FGFR-inhibitor (3i), we later dropped this treatment as it was found to be equivalent to the 2i condition in terms of blastocyst development, which is similar to the finding in the mouse [16] . A side effect of inhibiting MAPK and GSK3 from the zygote stage onward was the increased abundance of cumulus cells in bovine IVF cultures (Supplemental Fig. S1 ). This compromised blastocyst formation rate in cumulus-intact (248/823 ¼ 30% vs. 211/824 ¼ 26%, respectively, n ¼ 10, P , 0.05, Fig. 1B) but not cumulusfree DMSO versus 2i cultures (546/1653 ¼ 33% vs. 572/1674 ¼ 34%, respectively, n ¼ 15, P ¼ 0.51, Fig. 1C) . Overall, the high quality of blastocyst development (15% vs. 23%, respectively, P , 0.001) was significantly reduced in cumulus-intact versus cumulus-free 2i-treated embryo cultures (Fig. 1, B and C) . To tease out more subtle effects of signal inhibition under different culture regimes, we categorized each blastocyst according to its developmental stage. In general, signal inhibition increased the proportion of more advanced blastocysts ( Fig. 2A) . The acceleration of blastocyst formation was evident in cumulusintact (Fig. 2B ) and cumulus-free cultures (Fig. 2C) . Compared to DMSO, 2i cumulus-free cultures showed a significant increase in the proportion of hatching at the expense of early blastocysts (19/433 ¼ 4% vs. 7/416 ¼ 2% and 70/433 ¼ 16% vs. 93/416 ¼ 22%, respectively, n ¼ 11 independent IVF experiments, P , 0.05). Even though the proportion of transferable grade 1-2 embryos was not altered, blastocysts derived in 2i medium were recognizable by their exceptional morphological quality. This included a compact symmetrical ICM, a TE uniform in size, color, and density, and a general absence of extruded degenerating cells. Our qualitative impression was supported by differential staining (Supplemental Fig. S2 ) and quantification of the number of putative ICM, TE, and total cell nuclei ( Table 2) . In 2i culture, ICM, TE, and total cell numbers were equally increased by 30%, 27%, and 28%, respectively, compared to controls (57 vs. 44, 89 vs. 70, and 146 vs. 114, respectively, P , 0.01). There was no statistical difference between the 2i versus CHIR99021 group, suggesting that GSK inhibition was sufficient to increase the cell numbers. While PD0325901 alone did not affect cell numbers in the ICM, it stimulated trophoblast proliferation to the same extent as CHIR99021. However, the two inhibitors did not have an additive effect, indicating that they may converge on the same signaling pathway in the trophoblast. In all the subsequent experiments, we cultured cumulus-free zygotes in DMSO versus 2i until the blastocyst stage.
2i Alters Gene Expression in the ICM, but Not the Trophoblast Lineage
In order to correlate the changes in morphology and cell numbers with changes in lineage segregation, we next investigated expression of several pluripotency-related and 2i MEDIUM PROMOTES BOVINE EPIBLAST PLURIPOTENCY lineage-specific genes in 2i-derived blastocysts. Because of the limited availability of validated antibodies that specifically recognize a range of bovine candidate proteins, we restricted our analysis to quantifying the relative abundance of mRNA levels. Expression of pluripotency-related transcripts for POU5F1, KLF4, and DPPA3, which are not epiblast exclusive in bovine blastocysts at the stages analyzed (see below), was not significantly affected by dual kinase inhibition. NANOG and SOX2, putative markers of pluripotent epiblast cells, were both significantly increased (.3-fold, P , 0.001) over control levels (Fig. 3) . This effect was also observed when embryos were treated with CHIR99021 or PD0325901 inhibitor alone (Supplemental Fig. S3 ). By contrast, the putative hypoblast marker GATA4 was 2-fold down-regulated under 2i conditions (P , 0.05) while trophoblast-enriched CDX2 and IFNT showed no significant changes (Fig. 3) . The cell proliferation and growth-associated transcription factor C-MYC was also not affected by 2i.
2i Increases Pluripotency-Related Gene Expression Specifically in the ICM
We then sought to determine which cell type within the bovine blastocyst up-regulates expression of the pluripotencyrelated genes NANOG and SOX2. We microsurgically dissected the two subpopulations of blastocyst cells, ICM and TE, and analyzed them separately by qPCR (Fig. 4A) . In DMSO controls, NANOG was enriched in ICM versus TE tissues (3-fold, P , 0.05), while SOX2 and DPPA3 showed no significant differences in tissue distribution (Fig. 4B , P ¼ 0.51 and P ¼ 0.81, respectively). CDX2 was almost 8-fold more abundant in the TE (P , 0.001) Confirming our previous observations in whole blastocysts, NANOG and SOX2 levels were significantly increased in 2i compared to DMSO controls (Fig. 4B) . This increase was specific to the ICM portion (7-fold for NANOG and 3-fold for SOX2, P , 0.001 and P , 0.05, respectively), while the TE portion showed similarly low expression levels for both genes. Consequently, the differential between ICM 
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versus TE was much greater in 2i-derived blastocysts (21-fold and 7-fold for NANOG and SOX2, respectively, with P , 0.005 and P , 0.05, respectively). As observed previously in whole blastocysts, neither DPPA3 nor CDX2 showed significant changes in response to FGF-MAPK and GSK3 inhibition. GATA4 levels in bisected blastocysts were too low for reliable quantification (data not shown).
2i Primes Bovine Blastocysts for Derivation of Pluripotent ICM Cultures
In order to examine longer-term effects of 2i culture beyond the blastocyst stage, we cultured embryos in 2i or DMSO for 8 days and then isolated their ICMs. Explanted ICMs were cultured for another 6 days in medium without 2i. No obvious morphological differences were visible between the primary cultures derived from blastocysts with or without 2i medium (Fig. 5A) . However, gene expression of lineage-specific candidate markers NANOG and GATA4 differed markedly between the two treatments (Fig. 5B) . NANOG transcription in primary ICM cultures was increased by the presence of 2i in the embryo culture medium (P , 0.05). GATA4 expression was suppressed when 2i was included in the embryo culture medium (P , 0.005), and this effect was not reversible, even when 2i was removed during subsequent ICM culture. CDX2 levels, on the other hand, were not affected (P ¼ 0.52). These results show that 2i exposure during embryo culture has a longlasting effect on gene expression, even after subsequent 2i removal. 
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DISCUSSION
General 2i Effects on Bovine Blastocyst Development
Here we show that inhibition of MAP2K and GSK3 signaling improves blastocyst development and selectively increases expression of ICM-specific pluripotency genes. The 2i culture regime has been previously tested on mouse [16] , bovine [28] , and human [38] embryos. These studies have focused on the effect of dual kinase inhibition on protein expression and early lineage segregation in the developing blastocyst. Before discussing our results in this specific developmental context, we consider two general effects of 2i medium on bovine in vitro produced (IVP) embryos. First, 2i increased the number of cumulus cells in culture. This was unexpected as genetic or pharmacological inhibition of MAPK1/2 completely suppressed cumulus expansion during mouse and porcine oocyte maturation [39, 40] . Thus, cumulus cells in serum-free 2i embryo coculture may either no longer rely on MAPK signaling for proliferation or fail to undergo MAPK-mediated apoptosis. Both effects have been described for 2i/3i cultured pluripotent cell types [21, 41] . Alternatively, cumulus expansion may be explained by partial inhibition of GSK3. This stabilizes c-Myc [42] , a potent oncogene, and stimulates several ill-defined metabolic and biosynthetic processes [43] , augmenting cell proliferation and viability when MAPK is suppressed. Because we observed a compromising interaction between 2i-increased cumulus numbers and blastocyst development, we subsequently removed the cumulus corona prior to IVC. Second, 2i accelerated development and increased blastocyst quality. This may again be a result of stimulating anabolic processes via GSK3 inhibition because CHIR99021 alone was sufficient to increase cell numbers in the trophoblast and ICM. In bovine IVF embryos, CHIR99021 decreased phosphorylated b-catenin at the 2-cell stage and improved blastocyst rate and quality, indicating WNT stimulation [44] . A similar effect was not apparent in mouse embryos treated with broad-spectrum Map2k inhibitors [45] or 2i from the zygote stage [16] . The timing of the first cleavage positively correlates with in vitro developmental competence [46] , and it would be interesting to study this parameter more closely in 2i-treated embryos. Whilst fast cleavage kinetics predicts better morphology and hatching ability in bovine IVP embryos, it would be even more informative to evaluate the in vivo developmental potential of 2i-treated blastocysts.
2i Partially Converts Bovine Hypoblast into Epiblast
In late mouse blastocysts, pharmacological inhibition of the Fgf/Mapk module reprograms almost all Gata4-positive hypoblast into Nanog-positive epiblast [16] . This lineage respecification happens without reduction in ICM cell numbers, suggesting that Fgf/Mapk activates Gata4 and represses Nanog, thereby instructing direct hypoblast differentiation. Bovine hypoblast formation also depends on FGF/ MAPK signaling. Exogenous FGF2 stimulates hypoblast proliferation in blastocysts and outgrowth cultures [47] . FGF4 increases GATA6 expression, inhibiting NANOG and converting epiblast into hypoblast [28] . Consistent with this, chemical blockage of FGFR phosphorylation and signaling in late bovine blastocysts decreases GATA4 expression and increases NANOG [47] although this was not apparent at the protein level [28] . This discrepancy might be due to different inhibitor concentrations and exposure times in the two studies. FGF signaling is partially mediated by MAP2K because inhibiting the latter respecifies about one-third of GATA6-positive hypoblast into NANOG-positive epiblast cells [28] . Such modest level of lineage conversion, compared to mouse HARRIS ET AL. embryos exposed to similar inhibitor concentrations for a similar time, is unlikely to be due to incomplete MAP2K inhibition. This is because the inhibition targets are highly conserved in bovine versus mouse (99% and 97% for MAP2K1 and MAP2K2, respectively), with both homologues being amino acid identical in their unique binding pocket for structurally related MAPK inhibitors [48] . Accordingly, MAPK phosphorylation in bovine fibroblasts was completely inhibited by PD0325901 [49] . Mouse and bovine ICM cells may instead differ in the dozens of cytosolic and nuclear targets of phosphorylated MAPK1/2.
Downstream of Fgf4, Map2k inhibition does not activate Wnt signaling and Wnt does not inhibit Map2k function, suggesting that the two pathways converge later on [18] . In mouse blastocysts, CHIR99021 alone had no effect on the number of Nanog-positive cells [16] . However, in mouse embryonic stem (ES) cells, Nanog mRNA expression was significantly increased by CHIR99021 [50] . We also observed that CHIR99021 significantly increased both NANOG and SOX2 in bovine, supporting the moderate effect on upregulating NANOG protein previously described [28] . Thus, WNT signals may play a similar role in specifying bovine epiblast and/or suppressing hypoblast formation in both species. Gain-of-function studies with physiologically relevant exogenous WNT candidates would further corroborate the inhibitor experiments. Whilst TGFb receptor signaling via ALK5 was not essential for hypoblast formation [28] , other FGF/MAPK-independent candidate pathways remain to be tested for their ability to activate bovine GATA4/6 and repress NANOG expression or vice versa.
The ICM of expanded bovine blastocysts consists of about 75% GATA6-positive putative hypoblast and 25% NANOGpositive putative epiblast cells [28] . Because GATA6 mRNA proved difficult to quantify, we concentrated on GATA4. Although overall transcripts levels were low, GATA4 was 4-fold more abundant in the ICM than TE of bisected D8 blastocysts, justifying its use as a marker of bovine hypoblast precursors. As previously shown in ES cells, inhibiting MAPK signals increased relative levels of NANOG mRNA [51] . In analogy to mouse, this may have been due to Map2k inhibition Embryos were cultured in DMSO versus 2i medium for 8 days from the zygote stage, followed by 2i-free culture for another 6 days after ICM isolation. Bar ¼ 100 lm. B) NANOG, GATA4, and CDX2 levels were determined by qRT-PCR of D6 primary colonies, derived from blastocysts cultured in DMSO versus 2i. Target gene values were normalized on 18S expression in relative units (RU); n ¼ number of independent IVF experiments, and N ¼ number of blastocysts. Error bars indicate 6 SEM. ab Treatments with different superscripts differ, P , 0.05.
2i MEDIUM PROMOTES BOVINE EPIBLAST PLURIPOTENCY blocking nuclear export and thus stimulating nuclear accumulation of Tbx3, a T box transcription factor activating Nanog [51] . Depending on the sequence conservation between mouse versus bovine, NANOG activation would establish pluripotency in the ICM through direct repression of its target genes, such as GATA4/6 [52] , or interaction with its protein binding partners.
We further identified SOX2 as a pluripotency gene specifically up-regulated under 2i conditions. This has been observed recently [53] and could also be a direct consequence of MAPK-inhibition, antagonizing nuclear export of Tbx3 and leading to minor activation of Sox2 [51] . Direct stimulation of SOX2 transcription via increased NANOG levels appears less likely because Nanog overexpression only down-regulates its own transcription, presumably to prevent overactivation, without affecting other Oct/Sox target genes [54] . Because the identity and conservation of the Nanog cognate sequence is still controversial [55] , it is unclear if bovine NANOG even binds within the SOX2 promoter. Whether the 2i-induced increase in SOX2 mRNA abundance translates into a concomitant increase in protein levels needs to be confirmed in quantitative confocal studies. Even though Sox2 is the protein most often colocalizing with Nanog [55] , their binding relationship remains to be fully elucidated. In agreement with the Sox2/Nanog DNA-binding pattern, both proteins closely colocalize within the bovine ICM and are absent from the trophoblast [29] .
Expression of other genes within the pluripotent regulatory network, including POU5F1, KLF4, and DPPA3 was not affected by 2i. This suggests that they are neither directly controlled by MAPK and GSK3 signals, nor by increased NANOG/SOX2 levels. Limiting the potential effects of the latter, murine Klf4 is controlled by the Lif-Jak/Stat pathway [51] and lies upstream of Nanog and Sox2 [51, 56] , while Dppa3 is suppressed by Nanog [5] . Our data agree with previous reports that showed no up-regulation of Pou5f1 expression in 2i-treated mouse ES cells [9] or blastocysts [16] . Because there was no change in POU5F1 mRNA, its positively or negatively regulated tentative target genes (Klf4, Dppa3, or Cdx2, respectively) were minimally disturbed.
Related to the pluripotency-associated network is a module of highly connected binding sites centered around the transcription factor c-myc. Members of this module bind to targets associated with different epigenetic modifications from the common pluripotency genes [57] . Myc functions are distinct from the core pluripotency factors and mainly associated with protein metabolism [57] . Despite the overall increase in cell numbers of 2i-treated blastocysts, we observed no change in C-MYC levels.
Taken together, our data indicate species-specific differences in the signaling pathways and transcriptional regulatory networks governing hypoblast-epiblast segregation. Compared to mouse, bovine ICM cells depended less on MAP2K and more on WNT signals to control their conversion into epiblast via NANOG and SOX2 expression.
2i Does Not Impair Trophoblast Development
Despite initial reports to the contrary [58] , Mapk-inhibition did not impair murine trophoblast marker expression, lineage specification, and blastocoel formation in cultured mouse embryos [16] . Likewise, trophoblast-enriched CDX2 mRNA concentration was not affected in 2i-cultured bovine blastocysts. This is consistent with studies showing that CDX2 was neither affected by FGFR inhibition, nor by FGF2 supplementation [47] . However, murine trophoblast cells express FGF receptor [59] , and their proliferation was stimulated by Fgf4 [8] but reduced by 2i or Mapk-inhibition alone [16] . By contrast, we found that bovine trophoblast cell numbers increased in 2i medium, CHIR99021, or even PD0325901 alone. In other studies, the incidence of trophoblast outgrowth formation and proliferation remained unchanged in the presence of exogenous FGF2 [47] , while bovine trophoblast cell lines did not require FGF to survive, proliferate, and prevent differentiation [60, 61] . It remains to be determined whether other FGF effects, such as an increase of trophoblast migratory or chemotactic activity [62, 63] , are impaired by 2i culture.
In conclusion, we have confirmed species-specific differences in maintaining the trophoblast lineage via FGF signaling. This extends previous findings that uncovered divergence in the relative timing of TE commitment between mouse and cattle [64] . These recent advances illustrate that we need to define the molecular mechanisms underlying early lineage segregation in nonrodent species in order to determine if the naive pluripotent state is a conserved feature of mammalian embryogenesis. Until the derivation of naive PSCs from nonrodent embryos can be achieved without genetic intervention, the validity of this hypothesis remains open to question.
